Since chronic intestinal inflammation plays a key role in CRC initiation and progression 23, we evaluated the role of MD2 in TLR4 mediated-inflammatory responses and metastatic colon cancer growth in vitro and in vivo. This evidence concerns the gene TLR4 and colorectal carcinoma.